T-cell receptor constant region 1 antibody or T-cell receptor constant region 2 antibody
US11945867B2 · kind B2 · utility
0Cited by
0References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 21, 2019 |
| Grant date | Apr 2, 2024 |
| Priority date | — |
| Expiry date | Aug 14, 2041 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/7051
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention provides antibodies and polyclonal antibody preparations which bind the intracellular portion of either T-cell receptor constant region 2 (TRBC2) or T-cell receptor constant region 1 (TRBC1). The antibodies can be used to determine whether a T-cell malignancy clonally expresses TRBC1 or TRBC2.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.